These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 19221211

  • 1. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
    Torrens C, Kelsall CJ, Hopkins LA, Anthony FW, Curzen NP, Hanson MA.
    Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211
    [Abstract] [Full Text] [Related]

  • 2. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X, Ma Y, Ruan Y, Fu G, Wu S.
    Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
    [Abstract] [Full Text] [Related]

  • 3. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA, Liao JK, Hurley S, Garrett LA, Chui D, Mitra D, Creager MA.
    Circ Res; 2004 Jul 23; 95(2):217-23. PubMed ID: 15178637
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J, Kathirvel K, Leo MD, Kuntamallappanavar G, Uttam Singh T, Mishra SK.
    J Cardiovasc Pharmacol; 2009 Dec 23; 54(6):526-34. PubMed ID: 19755915
    [Abstract] [Full Text] [Related]

  • 5. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
    Zhou MS, Jaimes EA, Raij L.
    Hypertension; 2004 Aug 23; 44(2):186-90. PubMed ID: 15238570
    [Abstract] [Full Text] [Related]

  • 6. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM, Rodríguez-Criado N, Hernanz R, García-Redondo AB, Rodrigues-Díez RR, Alonso MJ, Egido J, Ruiz-Ortega M, Salaices M.
    Hypertension; 2009 Jul 23; 54(1):142-9. PubMed ID: 19451411
    [Abstract] [Full Text] [Related]

  • 7. Atorvastatin restores arsenic-induced vascular dysfunction in rats: modulation of nitric oxide signaling and inflammatory mediators.
    Kesavan M, Sarath TS, Kannan K, Suresh S, Gupta P, Vijayakaran K, Sankar P, Kurade NP, Mishra SK, Sarkar SN.
    Toxicol Appl Pharmacol; 2014 Oct 01; 280(1):107-16. PubMed ID: 25058445
    [Abstract] [Full Text] [Related]

  • 8. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N.
    J Gastroenterol Hepatol; 2012 Aug 01; 27(8):1353-61. PubMed ID: 22432744
    [Abstract] [Full Text] [Related]

  • 9. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, Itter G, Rösen R, Böhm M, Nickenig G.
    Hypertension; 2001 Jun 01; 37(6):1450-7. PubMed ID: 11408394
    [Abstract] [Full Text] [Related]

  • 10. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
    Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, Antonopoulos AS, Demosthenous M, Marinou K, Hale A, Paschalis A, Psarros C, Triantafyllou C, Bendall J, Casadei B, Stefanadis C, Channon KM.
    Circulation; 2011 Jul 19; 124(3):335-45. PubMed ID: 21730307
    [Abstract] [Full Text] [Related]

  • 11. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z, Guerard P, Lirussi F, Goirand F, Rochette L, Dumas M, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec 19; 374(3):195-206. PubMed ID: 17102939
    [Abstract] [Full Text] [Related]

  • 12. Effect of raloxifene and atorvastatin in atherosclerotic process in ovariectomized rats.
    Cetinkaya Demir B, Uyar Y, Ozbilgin K, Köse C.
    J Obstet Gynaecol Res; 2013 Jan 19; 39(1):229-36. PubMed ID: 22845341
    [Abstract] [Full Text] [Related]

  • 13. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide.
    Dayoub JC, Ortiz F, López LC, Venegas C, Del Pino-Zumaquero A, Roda O, Sánchez-Montesinos I, Acuña-Castroviejo D, Escames G.
    J Pineal Res; 2011 Oct 19; 51(3):324-30. PubMed ID: 21585521
    [Abstract] [Full Text] [Related]

  • 14. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
    Okamura T, Tawa M, Geddawy A, Shimosato T, Iwasaki H, Shintaku H, Yoshida Y, Masada M, Shinozaki K, Imamura T.
    J Pharmacol Sci; 2014 Oct 19; 124(1):76-85. PubMed ID: 24389820
    [Abstract] [Full Text] [Related]

  • 15. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M.
    Arterioscler Thromb Vasc Biol; 2000 Jan 19; 20(1):61-9. PubMed ID: 10634801
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids.
    Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, Antonioli L, Duranti E, Daghini E, Giannarelli C, Blandizzi C, Taddei S, Del Tacca M.
    Hypertension; 2009 Jun 19; 53(6):1008-16. PubMed ID: 19380610
    [Abstract] [Full Text] [Related]

  • 17. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
    Vecchione C, Brandes RP.
    Circ Res; 2002 Jul 26; 91(2):173-9. PubMed ID: 12142351
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
    Chen Y, Ku H, Zhao L, Wheeler DC, Li LC, Li Q, Varghese Z, Moorhead JF, Powis SH, Huang A, Ruan XZ.
    Arterioscler Thromb Vasc Biol; 2014 Feb 26; 34(2):365-76. PubMed ID: 24233489
    [Abstract] [Full Text] [Related]

  • 19. Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake.
    Fiore MC, Jimenez PM, Cremonezzi D, Juncos LI, García NH.
    Am J Physiol Renal Physiol; 2011 Aug 26; 301(2):F263-70. PubMed ID: 21543414
    [Abstract] [Full Text] [Related]

  • 20. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, Lamas S.
    J Clin Invest; 1998 Jun 15; 101(12):2711-9. PubMed ID: 9637705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.